期刊文献+

阿托伐他汀对华法林致大鼠主动脉中膜钙化及收缩压升高的影响 被引量:1

Effect of atorvastatin on aortic medial calcification and systolic blood pressure of rats induced by warfarin
下载PDF
导出
摘要 目的:探讨阿托伐他汀对华法林所致大鼠主动脉中膜钙化和收缩压的影响。方法:将健康成年Wistar大鼠30只随机分为华法林组(10只)、阿托伐他汀组(10只)和正常对照组(10只)。华法林组连续用华法林灌胃4周,正常对照组连续用等量生理盐水灌胃4周,他汀组在用华法林灌胃(15mg.kg-1.d-1)的同时给予阿托伐他汀(20mg.kg-1.d-1)灌胃。每周测鼠尾动脉压1次。4周后,取大鼠主动脉。观察弹性纤维和胶原纤维,以及中膜钙盐沉积。结果:华法林组动脉中膜有钙盐沉积,而他汀组钙盐沉积较华法林组明显减少。华法林组收缩压明显增高,而他汀组则明显降低由华法林诱导的大鼠收缩压升高(P<0.01)。结论:华法林能使大鼠主动脉中膜钙盐沉积,从而升高其收缩压;而阿托伐他汀能抑制华法林的上述作用,提示阿托伐他汀可能通过抑制华法林所致动脉中膜钙化而降低其收缩压。 OBJECTIVE To understand the effect of atorvastatin to aortic medial calcification and systolic blood pressure (SBP) of rats induced by warfarin. METttODS Healthy and adultrats were randomly divided into warfarin group ( 15 mg·kg^-1·d^-1 intragastric administration), atorvastatin group (20 mg·kg^-1·d^-1 intragastric administration) and normal control group. Caudal arterial pressure of rats were measured once a week, then got aorta after 4 weeks. Elastic fiber, collagen fiber and calcium accumulation in tunica media of aorta were measured by Von Kossa staining. RESULTS The warfarin treatment led to elevation of systolic blood pressure and aortic medial calcification. This chronic treatment also increased collagen, whereas elastin decreased in the aorta. However, the atorvastatin treatment had adverse effects. CONCLUSION Treatment with atorvastatin represent evidence of BP lowing and calcification reducing. These data demonstrate that atorvastatin protects aortic medial from warfarin-induced calcification and elevation of systolic blood pressure.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第20期1733-1736,共4页 Chinese Journal of Hospital Pharmacy
基金 湖北省科技攻关项目资助(编号:2002AA301B14)
关键词 阿托伐他汀 收缩压 血管钙化 atorvastatin systolic blood pressure vascular calcification
  • 相关文献

参考文献9

  • 1Paultre F, Mosca L. Association of blood pressure indices and stroke mortality in isolated systolic hypertension[J].Stroke, 2005,36(6) : 1288- 1290.
  • 2Mackey RH, Venkitachalam L, Sutton-Tyrrell K, etal. Calcifications, arterial stiffness and atherosclerosis[J].Adv Cardiol, 2007,44 : 234- 244.
  • 3Essalihi R, Dao HH, Yamaguchi N, etal. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment[J]. Am J Hypertens, 2003,16(2) : 103 -110.
  • 4Milionis H J, Liberopoulos EN, Achimastos A, et al. Statins: another class of ntihypertensive agents[J].J Hum Hypertens, 2006,20 (5) : 320-335.
  • 5Donnell CJ, Shea MK, Price PA, et al. Matrix gla protein is associated with risk factors for atherosclerosis but not with coronary artery caleification[J]. Arterioscler Thromb Vasc Biol, 2006 ,26(12) :2769-2774.
  • 6Son BK, Kozaki K, Iijima K,et al. Statins protect human aor tie smooth muscle cells from inorganic phosphate induced calci fication by restoring gas6-axl survival pathway[J]. Circ Res, 2006,98(8) : 1024-1031.
  • 7Son BK, Kozaki K,Iijima K, et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells [J]. Eur J Pharmacol, 2007, 556(1-3):1-8.
  • 8Rajamannan NM, Subramaniam M, Stock SR, etal. Atorvas tatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve[J]. Heart, 2005,91(6) :806-810.
  • 9Strazzullo P, Kerry SM, Barbato A, etal. statins reduce blood pressure? a meta analysis of randomized, controlled trials[J]. Hypertension, 2007,49 (4): 792- 798.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部